AML - NPM1
The NPM1 gene mutation test is done to confirm or deny the presence of the NPM1 strain in the DNA of a person suffering from Acute Myeloid Leukemia or AML. This gives doctors a better idea regarding the prognosis and also regarding the chances of success with certain treatments for AML.
- No special preparation required
NPM1 gene testing is done to locate the specific gene in a person with AML. The presence of NPM1 in people with the FLT3 ligand, suggests a hopeful prognosis. This means that these people are more likely to recover from AML than others.
The results can either be positive or negative. A positive result indicates that the person does have a NPM1 gene mutation. However, a negative result indicates the absence of such a mutation in the gene strain.
ABOUT US
Medical Network Pvt. Ltd. offers trusted and user-friendly online pharmacy and healthcare services, providing quality medicines and healthcare solutions.
Join our monthly newsletter
What our customer says
Sri M.
Jalandhar
M.Apte
Mumbai
J.Singh
New Delhi
M.Kaur
Chandigarh
T.Yadav
Patna
